Condition: Chronic Kidney Disease · Sponsor: Novo Nordisk A/S
The study evaluates the safety of different doses of a new medicine called NNC0519 0130. It also looks into how the medicine may improve kidney function in participants with chronic kidney disease with or without type 2 diabetes, living with overweight or obesity. The participants will either get NNC0519-0130 (a new medicine), semaglutide (a medicine that doctors can already prescribe), or placebo (a "dummy" substance). Which treatment the participant will get is decided by chance. The study will last for up to 43 weeks.
This description comes directly from the study's public registry record.
Novo Nordisk · (+1) 866-867-7178 · clinicaltrials@novonordisk.com
Always discuss trial participation with your own doctor first.
| N America Res Inst - San Dimas | San Dimas, California, United States | Active Not Recruiting |
| NorCal Endocrinology and Internal Medicine | San Ramon, California, United States | Active Not Recruiting |
| Rocky Mount Reg VA Med-DN | Aurora, Colorado, United States | Completed |
| Northeast Research Institute | Fleming Island, Florida, United States | Active Not Recruiting |
| Encore Medical Research LLC | Hollywood, Florida, United States | Active Not Recruiting |
| Northeast Research Institute | Saint Augustine, Florida, United States | Active Not Recruiting |
| Clinical Research of Cent FL | Winter Haven, Florida, United States | Completed |
| Endeavor Health | Skokie, Illinois, United States | Completed |
| Velocity Clin. Res Valparaiso | Valparaiso, Indiana, United States | Active Not Recruiting |
| Elite Research Center | Flint, Michigan, United States | Completed |
| Clinical Research Consultants | Kansas City, Missouri, United States | Active Not Recruiting |
| Albany Medical College | Albany, New York, United States | Active Not Recruiting |
+ 135 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06717698